As Director of Bioinformatics at OMass Therapeutics, I specialize in developing advanced bioinformatics strategies, including an AI-enabled target identification pipeline and Graph Machine Learning for Knowledge Graph analysis. At Novo Nordisk Research Centre Oxford, I led significant T2D research projects, integrating GWAS data for micropeptide discovery and spearheading drug target discovery collaborations.
With expertise in programming languages like Python and R, and skills in AI, bioinformatics, and systems biology, my career spans innovative contributions to cancer detection technology and drug discovery. My leadership is further reinforced by extensive project management experience, making me a valuable asset in bioinformatics research and development.
